Hims & Hers Health, Inc. — Form 8-K Summary
Business context and reporting period
Hims & Hers Health, Inc. filed this current report regarding its Annual Meeting of Stockholders held on June 1, 2023. The filing reports shareholder voting results and does not present quarterly or annual operating results.
Key financial and capital metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
As of the April 14, 2023 record date, 200,934,997 shares of Class A common stock and 8,377,623 shares of Class V common stock were outstanding and entitled to vote. Class A shares carried one vote per share, while Class V shares carried 175 votes per share. Both classes voted together as a single class.
Meeting results and material changes
- Director elections: All nine nominees were elected to serve until the 2024 annual meeting and until their successors are elected and qualified. Broker non-votes totaled 27,820,587 for each nominee.
- Auditor ratification: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, with 1,572,576,823 votes for, 784,991 against, and 341,677 abstentions.
- Executive compensation: Stockholders approved, on an advisory basis, the Company’s executive compensation, with 1,529,000,617 votes for, 16,445,485 against, 436,802 abstentions, and 27,820,587 broker non-votes.
The filing text does not report material changes to the Company’s financial condition, operations, guidance, or outlook versus a prior comparable period.
Guidance, risks, contingencies, and unusual items
No financial guidance, management outlook, contingencies, or operating risk updates are provided. The dual-class voting structure and 175-to-one voting ratio for Class V shares are material governance considerations.
Investor verification points
- Review the definitive proxy statement filed April 28, 2023 for proposal details and governance disclosures.
- Assess the effect of the Class V super-voting structure on shareholder control and voting outcomes.
- Confirm the nine directors’ continued service and KPMG LLP’s appointment for fiscal 2023.
- Use the Company’s periodic financial filings for revenue, profitability, cash flow, liquidity, debt, and forward guidance, none of which are included in this Form 8-K.